|

Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study

RECRUITINGN/ASponsored by Pharmicell Co., Ltd.
Actively Recruiting
PhaseN/A
SponsorPharmicell Co., Ltd.
Started2021-08-24
Est. completion2026-08-24
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05093881

Summary

This Long-term follow-up is designed to evaluate the safety of patient with Alcoholic Liver Cirrhosis who had administered Cellgram-LC in PMC-P-07 study.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

1. Those who participated in PMC-P-07 clinical trials and received Cellgram-LC
2. Those who voluntarily agreed in writing to participate in this investigation

Exclusion Criteria:

\-

Conditions2

Alcoholic CirrhosisLiver Disease

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.